<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  
    
  <dc:publisher>MDPI</dc:publisher>
    
  
    
  <dc:date>2024</dc:date>
    
  
    
  <dc:relation>isPartOf:https://phaidra.vetmeduni.ac.at/o:605</dc:relation>
    
  
    
  <dc:rights>CC BY 4.0 International</dc:rights>
    
  <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
    
  
    
  <dc:identifier>doi:10.3390/cancers16020375</dc:identifier>
    
  <dc:identifier>https://phaidra.vetmeduni.ac.at/o:3075</dc:identifier>
    
  
    
  <dc:description xml:lang="eng">Tumor neoangiogenesis is an important hallmark of cancer progression, triggered by alternating selective pressures from the hypoxic tumor microenvironment. Non-invasive, non-contrast-enhanced multiparametric MRI combining blood-oxygen-level-dependent (BOLD) MRI, which depicts blood oxygen saturation, and intravoxel-incoherent-motion (IVIM) MRI, which captures intravascular and extravascular diffusion, can provide insights into tumor oxygenation and neovascularization simultaneously. Our objective was to identify imaging markers that can predict hypoxia-induced angiogenesis and to validate our findings using multiplexed immunohistochemical analyses. We present an in vivo study involving 36 female athymic nude mice inoculated with luminal A, Her2+, and triple-negative breast cancer cells. We used a high-field 9.4-tesla MRI system for imaging and subsequently analyzed the tumors using multiplex immunohistochemistry for CD-31, PDGFR-β, and Hif1-α. We found that the hyperoxic-BOLD-MRI-derived parameter ΔR2* discriminated luminal A from Her2+ and triple-negative breast cancers, while the IVIM-derived parameter fIVIM discriminated luminal A and Her2+ from triple-negative breast cancers. A comprehensive analysis using principal-component analysis of both multiparametric MRI- and mpIHC-derived data highlighted the differences between triple-negative and luminal A breast cancers. We conclude that multiparametric MRI combining hyperoxic BOLD MRI and IVIM MRI, without the need for contrast agents, offers promising non-invasive markers for evaluating hypoxia-induced angiogenesis.</dc:description>
    
  
    
  <dc:creator>Bartsch, Silvester J. (Medical University of Vienna)</dc:creator>
    
  <dc:creator>Pinker, Katja (Memorial Sloan Kettering Cancer Center)</dc:creator>
    
  <dc:creator>Helbich, Thomas H. (Medical University of Vienna)</dc:creator>
    
  <dc:creator>Laimer-Gruber, Daniela (Medical University of Vienna)</dc:creator>
    
  <dc:creator>Kenner, Lukas (University of Veterinary Medicine Vienna / Medical University of Vienna)</dc:creator>
    
  <dc:creator>Fürböck, Christoph (Medical University of Vienna)</dc:creator>
    
  <dc:creator>Friske, Joachim (Medical University of Vienna)</dc:creator>
    
  <dc:creator>Brožová, Klára (University of Veterinary Medicine Vienna / Medical University of Vienna)</dc:creator>
    
  <dc:creator>Ehret, Viktoria (Medical University of Vienna)</dc:creator>
    
  
    
  <dc:title xml:lang="eng">Non-Contrast-Enhanced Multiparametric MRI of the Hypoxic Tumor Microenvironment Allows Molecular Subtyping of Breast Cancer: A Pilot Study</dc:title>
    
  
    
  <dc:type xml:lang="eng">article</dc:type>
    
  
    
  <dc:format>application/pdf</dc:format>
    
  
    
  <dc:source>Cancers 16(2) (2024)</dc:source>
    
  
    
  <dc:subject xml:lang="eng">Angiogenesis; Hallmarks; Diffusion; Expression; Pericytes; Receptor; Benign; Hif-1</dc:subject>
    
  
    
  <dc:language>eng</dc:language>
    
  
</oai_dc:dc>
